Joseph Horrigan
Chief Tech/Sci/R&D Officer at AMO Pharma Ltd.
Joseph Horrigan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Joseph Horrigan
Former positions of Joseph Horrigan
| Companies | Position | Start | End |
|---|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | 2012-08-09 | - |
Training of Joseph Horrigan
| Rochester Christian University | Doctorate Degree |
Statistics
International
| United States | 3 |
| Australia | 2 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Joseph Horrigan
- Experience
